FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W333696768> ?p ?o ?g. }

• W333696768 abstract "ABSTRACT In an attempt to improve outcomes for patients with acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT), we conducted a Phase I/II study in which targeted irradiation delivered by 131 I-anti-CD45 antibody was combined with targeted busulfan (BU; area-under-curve, 600-900 ng/ml) and cyclophosphamide (CY; 120 mg/kg). Fifty-two of 59 patients (88%) receiving a trace 131 I-labeled dose of 0.5 mg/kg anti-CD45 murine antibody had higher estimated absorbed radiation in bone marrow and spleen than in any other organ. Forty-six patients were treated with 102-298 mCi 131 I delivering an estimated 5.3-19 (mean 11.3) Gy to marrow, 17-72 (mean 29.7) Gy to spleen, and 3.5 Gy (n=4) to 5.25 Gy (n=42) to the liver. The estimated 3-year non-relapse mortality and disease-free survival (DFS) were 21% and 61%, respectively. These results were compared to those from 509 similar International Bone Marrow Transplant Registry patients transplanted using BU/CY alone. After adjusting for differences in age and cytogenetics-risk, the hazard of mortality among all antibody-treated patients was 0.65 times that of the Registry patients (95% CI 0.39-1.08; p=.09). The addition of targeted hematopoietic irradiation to conventional BU/CY is feasible and well tolerated, and Phase II results are sufficiently encouraging to warrant further study." @default.
• W333696768 created "2016-06-24" @default.
• W333696768 creator A5004025497 @default.
• W333696768 creator A5004610095 @default.
• W333696768 creator A5016751259 @default.
• W333696768 creator A5025579054 @default.
• W333696768 creator A5027410015 @default.
• W333696768 creator A5034117075 @default.
• W333696768 creator A5040412322 @default.
• W333696768 creator A5050992845 @default.
• W333696768 creator A5053711811 @default.
• W333696768 creator A5056405520 @default.
• W333696768 creator A5056983267 @default.
• W333696768 creator A5059063645 @default.
• W333696768 creator A5062488059 @default.
• W333696768 creator A5066347543 @default.
• W333696768 creator A5076899086 @default.
• W333696768 creator A5091433944 @default.
• W333696768 date "2013-01-01" @default.
• W333696768 modified "2023-09-23" @default.
• W333696768 title "ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR TREATMENT OF ACUTE MYELOID LEUKEMIA IN FIRST REMISSION" @default.
• W333696768 cites W124412411 @default.
• W333696768 cites W1485390964 @default.
• W333696768 cites W1491993932 @default.
• W333696768 cites W1492609361 @default.
• W333696768 cites W1504399806 @default.
• W333696768 cites W1534965621 @default.
• W333696768 cites W1576593419 @default.
• W333696768 cites W1577606693 @default.
• W333696768 cites W1579352764 @default.
• W333696768 cites W1586473141 @default.
• W333696768 cites W1588945047 @default.
• W333696768 cites W1597905058 @default.
• W333696768 cites W1605162359 @default.
• W333696768 cites W1628263893 @default.
• W333696768 cites W169590802 @default.
• W333696768 cites W1730814954 @default.
• W333696768 cites W1740151497 @default.
• W333696768 cites W1839751882 @default.
• W333696768 cites W1931731730 @default.
• W333696768 cites W1935387907 @default.
• W333696768 cites W1940241583 @default.
• W333696768 cites W1940470585 @default.
• W333696768 cites W1945721659 @default.
• W333696768 cites W1954992673 @default.
• W333696768 cites W1973018895 @default.
• W333696768 cites W1973617793 @default.
• W333696768 cites W1977384601 @default.
• W333696768 cites W1997928845 @default.
• W333696768 cites W2002051579 @default.
• W333696768 cites W2010213032 @default.
• W333696768 cites W2013051826 @default.
• W333696768 cites W2023760011 @default.
• W333696768 cites W2026597916 @default.
• W333696768 cites W2036351237 @default.
• W333696768 cites W2041821006 @default.
• W333696768 cites W2058743725 @default.
• W333696768 cites W2084493022 @default.
• W333696768 cites W2096057211 @default.
• W333696768 cites W2108635678 @default.
• W333696768 cites W2113491736 @default.
• W333696768 cites W2120818780 @default.
• W333696768 cites W2128997140 @default.
• W333696768 cites W2129834424 @default.
• W333696768 cites W2147977413 @default.
• W333696768 cites W2151123287 @default.
• W333696768 cites W2164532418 @default.
• W333696768 cites W2165725317 @default.
• W333696768 cites W2169733452 @default.
• W333696768 cites W2171140185 @default.
• W333696768 cites W2215316452 @default.
• W333696768 cites W2269690597 @default.
• W333696768 cites W2273204150 @default.
• W333696768 cites W2315152253 @default.
• W333696768 cites W2320751441 @default.
• W333696768 cites W2337969406 @default.
• W333696768 cites W2348973547 @default.
• W333696768 cites W2401363558 @default.
• W333696768 cites W2412475735 @default.
• W333696768 cites W2415953746 @default.
• W333696768 cites W71007469 @default.
• W333696768 hasPublicationYear "2013" @default.
• W333696768 type Work @default.
• W333696768 sameAs 333696768 @default.
• W333696768 citedByCount "0" @default.
• W333696768 crossrefType "journal-article" @default.
• W333696768 hasAuthorship W333696768A5004025497 @default.
• W333696768 hasAuthorship W333696768A5004610095 @default.
• W333696768 hasAuthorship W333696768A5016751259 @default.
• W333696768 hasAuthorship W333696768A5025579054 @default.
• W333696768 hasAuthorship W333696768A5027410015 @default.
• W333696768 hasAuthorship W333696768A5034117075 @default.
• W333696768 hasAuthorship W333696768A5040412322 @default.
• W333696768 hasAuthorship W333696768A5050992845 @default.
• W333696768 hasAuthorship W333696768A5053711811 @default.
• W333696768 hasAuthorship W333696768A5056405520 @default.
• W333696768 hasAuthorship W333696768A5056983267 @default.
• W333696768 hasAuthorship W333696768A5059063645 @default.
• W333696768 hasAuthorship W333696768A5062488059 @default.
• W333696768 hasAuthorship W333696768A5066347543 @default.

• next